HIF1A and acute promyelocytic leukemia: It is known that ATRA treatment increases the expression of HIF-1α in acute promyelocitic leukemia and in other cell types31, and more remarkably, that HIF-1α inhibition cooperates with ATRA in the reduction of APL disease32.